The prognostic significance of lymph nodes in patients with pT1c33N0M0 non-small cell lung cancer: a retrospective study

被引:0
作者
Yang, Wei [1 ,2 ]
Wang, Luyi [1 ,2 ]
机构
[1] Capital Med Univ, Beijing Chest Hosp, Dept Thorac Surg, Beijing, Peoples R China
[2] Capital Med Univ, Rehabil Diag & Treatment Ctr, Beijing Rehabil Hosp, Beijing, Peoples R China
关键词
-small cell lung cancer; Lymph nodes; Short-term prognosis; Prediction; OPEN-LABEL; RADIOTHERAPY;
D O I
10.7717/peerj.16866
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective. The objective of this study was to appraise the prognostic impact of lymph nodes in patients diagnosed with pT1c33N0M0 non-small cell lung cancer (NSCLC) and to delve into the prognostic significance of lymph nodes located at the N1 lymph node station in this patient cohort. Methods. A retrospective analysis of clinical data was conducted for 255 patients diagnosed with pT1c33N0M0 NSCLC. Lymph nodes were tabulated and categorized into three groups (0-10 nodes, 11-16 nodes, >16 nodes). Clinical data among these three groups of pT1c33N0M0 NSCLC patients were compared. We conducted both univariate and multivariate analyses to pinpoint the factors that impact the prognosis of patients with pT1c33N0M0 non-small cell lung cancer (NSCLC). Additionally, we employed receiver operating characteristic (ROC) curve analysis to pinpoint the optimal lymph node criteria at the N1 station for prognostic prediction in pT1c33N0M0 NSCLC patients. Results. Within the cohort of 255 individuals afflicted with pT1c33N0M0 non-small cell lung cancer (NSCLC), a comprehensive tally of 3,902 lymph nodes was diligently established, yielding an average of 15.3 nodes for each patient. Multivariate analysis demonstrated that tumor size, T stage, and lymph nodes were independent factors significantly impacting the prognosis of pT1c33N0M0 NSCLC patients (P < 0.05). ROC curve analysis revealed an area under the curve of 0.6982 for predicting prognosis using N1 station in pT1c33N0M0 NSCLC patients. The maximum Youden index was observed at an N1 station of 2.7 nodes. Patients with N1 station >= three nodes had significantly better prognoses compared to those with < 3 nodes (both P < 0.05). Conclusion. Lymph nodes serve as an independent prognostic factor for pT1c33N0M0 NSCLC patients. Detecting at least three or more lymph nodes at the N1 station is associated with a more favourable prognosis in pT1c33N0M0 NSCLC patients.
引用
收藏
页数:13
相关论文
共 21 条
[1]   The International Association for the Study of Lung Cancer Lung Cancer Staging Project Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer [J].
Asamura, Hisao ;
Chansky, Kari ;
Crowley, John ;
Goldstraw, Peter ;
Rusch, Valerie W. ;
Vansteenkiste, Johan F. ;
Watanabe, Hirokazu ;
Wu, Yi-Long ;
Zielinski, Marcin ;
Ball, David ;
Rami-Porta, Ramon .
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (12) :1675-1684
[2]   The Role of Sublobar Resection for the Surgical Treatment of Non-Small Cell Lung Cancer [J].
Behinaein, Parnia ;
Treffalls, John ;
Hutchings, Hollis ;
Okereke, Ikenna C. .
CURRENT ONCOLOGY, 2023, 30 (07) :7019-7030
[3]   Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery [J].
Chang, Joe Y. ;
Mehran, Reza J. ;
Feng, Lei ;
Verma, Vivek ;
Liao, Zhongxing ;
Welsh, James W. ;
Lin, Steven H. ;
O'Reilly, Michael S. ;
Jeter, Melenda D. ;
Balter, Peter A. ;
McRae, Stephen E. ;
Berry, Donald ;
Heymach, John, V ;
Roth, Jack A. .
LANCET ONCOLOGY, 2021, 22 (10) :1448-1457
[4]   NSCLC patients with a changing T grade after operation may represent a special subset of tumor staging [J].
Feng, Kun-Peng ;
Fu, Kai ;
Xu, Chun ;
Ding, Cheng ;
Zhu, Xin-Yu ;
Pan, Bin ;
Jia, Xin-Yu ;
Zhao, Jun ;
Li, Chang .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) :9991-9998
[5]   Treatment of Stage I Lung Cancer Detected by Computed Tomography Screening [J].
Gierada, David S. ;
Bai, Yun Zhu ;
Spraker, Matthew B. ;
Stilinovic, Anne ;
Nava, Ruben G. .
JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (10)
[6]  
Gronberg BH, 2021, LANCET ONCOL, V22, P321, DOI 10.1016/S1470-2045(20)30742-7
[7]   FOXM1 Variant Contributes to Gefitinib Resistance via Activating Wnt/β-Catenin Signal Pathway in Patients with Non-Small Cell Lung Cancer [J].
Guan, Shaoxing ;
Chen, Xi ;
Chen, Youhao ;
Xie, Wen ;
Liang, Heng ;
Zhu, Xia ;
Yang, Yunpeng ;
Fang, Wenfeng ;
Huang, Yan ;
Zhao, Hongyun ;
Zhuang, Wei ;
Liu, Shu ;
Huang, Min ;
Wang, Xueding ;
Zhang, Li .
CLINICAL CANCER RESEARCH, 2022, 28 (17) :3770-3784
[8]   A Combination of Biomarkers Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer [J].
Jiang, Zedong ;
Zhou, Yao ;
Huang, Juan .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[9]   Prognosis of segmentectomy and lobectomy for radiologically aggressive small-sized lung cancer [J].
Kamigaichi, Atsushi ;
Tsutani, Yasuhiro ;
Mimae, Takahiro ;
Miyata, Yoshihiro ;
Ito, Hiroyuki ;
Nakayama, Haruhiko ;
Ikeda, Norihiko ;
Okada, Morihito .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2020, 58 (06) :1245-1253
[10]   Prognostic Impact of the Number of Metastatic Lymph Nodes on the Eighth Edition of the TNM Classification of NSCLC [J].
Katsumata, Shinya ;
Aokage, Keiju ;
Ishii, Genichiro ;
Nakasone, Shoko ;
Sakai, Takashi ;
Okada, Satoshi ;
Miyoshi, Tomohiro ;
Tane, Kenta ;
Tsuboi, Masahiro .
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (08) :1408-1418